Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2014 Volume 9 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2014 Volume 9 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy

  • Authors:
    • Jie Zhang
    • Jianjun Xiu
    • Yin Dong
    • Muwen Wang
    • Xue Han
    • Yejun Qin
    • Zhaoqin Huang
    • Shifeng Cai
    • Xianshun Yuan
    • Qingwei Liu
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, Provincial Hospital, Shandong University, Jinan 250021, P.R. China, Minimally Invasive Urology Center, Provincial Hospital, Shandong University, Jinan 250021, P.R. China, Department of Pathology, Provincial Hospital, Shandong University, Jinan 250021, P.R. China
  • Pages: 1989-1997
    |
    Published online on: February 28, 2014
       https://doi.org/10.3892/mmr.2014.1994
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The Gleason grading system is a fundamental indicator of the aggressive nature of prostate cancer (PCa). Diffusion‑weighted imaging (DWI) and magnetic resonance (MR) spectroscopy (MRS) are methods for the assessment of PCa aggressiveness. The present study was designed to prospectively investigate whether transrectal ultrasound (TRUS)‑guided MR imaging (MRI)‑directed biopsies (TRUS‑MR‑Dbs) improve the prediction of PCa aggressiveness in comparison with 12‑core TRUS‑guided biopsies (TRUS‑Gbs). A total of 518 patients underwent pre‑biopsy multi‑parametric MRI to identify the clinically suspicious PCa regions. TRUS‑MR‑Dbs were performed on patients with suspected PCa by MRI in addition to TRUS‑Gbs. Only patients who underwent radical prostatectomy (RP) were included in the comparative analysis. TRUS‑biopsy was directed to those areas within suspicious regions with a minimum apparent diffusion coefficient obtained by DWI or with a maximum (choline + creatine)/citrate ratio obtained by MRS. The highest Gleason grades (HGGs) and the Gleason scores (GSs) of specimens were identified. The biopsies and RP results were evaluated using a McNemar test or χ2 analyses using Fisher' exact tests. MRI results were positive in 254 (49.0%) of the 518 patients. TRUS‑MR‑Db detected 165/254 (65.0%) cancer cases and TRUS‑Gb detected 190/518 (36.7%) cancer cases. Forty patients underwent RP. The TRUS‑MR‑Dbs method demonstrated a higher concordance rate (CR) with RP (89.6%) than TRUS‑Gbs (72.9%, P=0.008) for the overall HGG. The CRs with RP for TRUS‑MR‑Dbs vs. those for TRUS‑Gbs were 100 vs. 85.7% (P=0.5), 87.5 vs. 68.8% (P=0.031) and 50 vs. 50% (P=1) for HGG3, HGG4 and HGG5, respectively. The HGG CRs with RP for DWI‑directed biopsies (DWI‑Dbs) vs. MRS‑directed biopsies (MRS‑Dbs) were 77.1 vs. 50.0% (P=0.015) for the overall tumors, 80.0 vs. 40.0% (P=0.003) for peripheral zone tumors and 69.2 vs. 76.9% (P=1) for transition zone tumors. A total of 37 (77.1%) and 25 (52.1%; P=0.007) tumors were assigned accurate GS for TRUS‑MR‑Dbs and TRUS‑Gbs, respectively. The results revealed that TRUS‑MR‑Dbs improved the prediction of PCa aggressiveness and that DWI‑Dbs had a superior performance when compared with MRS‑Dbs in the peripheral zone.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Gleason DF and Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 111:58–64. 1974.

2 

Egevad L, Granfors T, Karlberg L, Bergh A and Stattin P: Prognostic value of the Gleason score in prostate cancer. BJU Int. 89:538–542. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Yang CW, Lin TP, Huang YH, et al: Does extended prostate needle biopsy improve the concordance of Gleason scores between biopsy and prostatectomy in the Taiwanese population? J Chin Med Assoc. 75:97–101. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Divrik RT, Eroglu A, Sahin A, Zorlu F and Ozen H: Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Urol Oncol. 25:376–382. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Delongchamps NB, Rouanne M, Flam T, et al: Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int. 107:1411–1418. 2011. View Article : Google Scholar

6 

Mazaheri Y, Shukla-Dave A, Hricak H, et al: Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings. Radiology. 246:480–488. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Park BK, Park JW, Park SY, et al: Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol. 197:W876–W881. 2011. View Article : Google Scholar

8 

Haffner J, Lemaitre L, Puech P, et al: Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int. 108:E171–E178. 2011. View Article : Google Scholar

9 

Pinto PA, Chung PH, Rastinehad AR, et al: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol. 186:1281–1285. 2011. View Article : Google Scholar

10 

Vourganti S, Rastinehad A, Yerram NK, et al: Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. 188:2152–2157. 2012. View Article : Google Scholar

11 

Kobus T, Vos PC, Hambrock T, et al: Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Radiology. 265:457–467. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Hambrock T, Somford DM, Huisman HJ, et al: Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 259:453–461. 2011. View Article : Google Scholar

13 

Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, et al: In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. Eur Urol. 60:1074–1080. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Scheenen TW, Heijmink SW, Roell SA, et al: Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology. 245:507–516. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Wang XZ, Wang B, Gao ZQ, et al: Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging. 29:1360–1366. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Wang XZ, Wang B, Gao ZQ, et al: 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. Eur J Radiol. 73:345–351. 2010. View Article : Google Scholar

17 

Stackhouse DA, Sun L, Schroeck FR, et al: Factors predicting prostatic biopsy Gleason sum under grading. J Urol. 182:118–124. 2009. View Article : Google Scholar

18 

Zakian KL, Sircar K, Hricak H, et al: Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 234:804–814. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Delongchamps NB, Peyromaure M, Schull A, et al: Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol. 189:493–499. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Moore CM, Robertson NL, Arsanious N, et al: Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol. 63:125–140. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Verma S, Rajesh A, Morales H, et al: Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol. 196:374–381. 2011. View Article : Google Scholar : PubMed/NCBI

22 

San Francisco IF, DeWolf WC, Rosen S, Upton M and Olumi AF: Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol. 169:136–140. 2003.PubMed/NCBI

23 

Park BK, Lee HM, Kim CK, Choi HY and Park JW: Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol. 43:789–793. 2008. View Article : Google Scholar

24 

Prando A, Kurhanewicz J, Borges AP, Oliveira EM Jr and Figueiredo E: Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology. 236:903–910. 2005. View Article : Google Scholar

25 

Tamada T, Sone T, Jo Y, et al: Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging. 28:720–726. 2008. View Article : Google Scholar

26 

Hambrock T, Hoeks C, Hulsbergen-van de Kaa C, et al: Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 61:177–184. 2012. View Article : Google Scholar

27 

Na R, Jiang H, Kim ST, et al: Outcomes and treands of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011. PLoS One. 7:e499142012. View Article : Google Scholar : PubMed/NCBI

28 

Miyagawa T, Ishikawa S, Kimura T, et al: Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data. Int J Urol. 17:855–860. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Rastinehad AR, Baccala AA Jr, Chung PH, et al: D’Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol. 185:815–820. 2011.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang J, Xiu J, Dong Y, Wang M, Han X, Qin Y, Huang Z, Cai S, Yuan X, Liu Q, Liu Q, et al: Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy. Mol Med Rep 9: 1989-1997, 2014.
APA
Zhang, J., Xiu, J., Dong, Y., Wang, M., Han, X., Qin, Y. ... Liu, Q. (2014). Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy. Molecular Medicine Reports, 9, 1989-1997. https://doi.org/10.3892/mmr.2014.1994
MLA
Zhang, J., Xiu, J., Dong, Y., Wang, M., Han, X., Qin, Y., Huang, Z., Cai, S., Yuan, X., Liu, Q."Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy". Molecular Medicine Reports 9.5 (2014): 1989-1997.
Chicago
Zhang, J., Xiu, J., Dong, Y., Wang, M., Han, X., Qin, Y., Huang, Z., Cai, S., Yuan, X., Liu, Q."Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy". Molecular Medicine Reports 9, no. 5 (2014): 1989-1997. https://doi.org/10.3892/mmr.2014.1994
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, Xiu J, Dong Y, Wang M, Han X, Qin Y, Huang Z, Cai S, Yuan X, Liu Q, Liu Q, et al: Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy. Mol Med Rep 9: 1989-1997, 2014.
APA
Zhang, J., Xiu, J., Dong, Y., Wang, M., Han, X., Qin, Y. ... Liu, Q. (2014). Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy. Molecular Medicine Reports, 9, 1989-1997. https://doi.org/10.3892/mmr.2014.1994
MLA
Zhang, J., Xiu, J., Dong, Y., Wang, M., Han, X., Qin, Y., Huang, Z., Cai, S., Yuan, X., Liu, Q."Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy". Molecular Medicine Reports 9.5 (2014): 1989-1997.
Chicago
Zhang, J., Xiu, J., Dong, Y., Wang, M., Han, X., Qin, Y., Huang, Z., Cai, S., Yuan, X., Liu, Q."Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy". Molecular Medicine Reports 9, no. 5 (2014): 1989-1997. https://doi.org/10.3892/mmr.2014.1994
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team